Surgery Today

, Volume 46, Issue 12, pp 1394–1401

Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer

  • Takashi Suzuki
  • Hideaki Shimada
  • Tatsuki Nanami
  • Yoko Oshima
  • Satoshi Yajima
  • Masaaki Ito
  • Naohiro Washizawa
  • Hironori Kaneko
Original Article

DOI: 10.1007/s00595-016-1339-z

Cite this article as:
Suzuki, T., Shimada, H., Nanami, T. et al. Surg Today (2016) 46: 1394. doi:10.1007/s00595-016-1339-z

Abstract

Purpose

Hyperfibrinogenemia is associated with poor prognosis in various cancers; however, its clinical relevance in gastric cancer has not been well analyzed. We conducted this study to assess the clinicopathological significance and prognostic value of hyperfibrinogenemia in patients with gastric cancer.

Methods

Plasma fibrinogen levels were measured preoperatively in 315 patients undergoing surgery for gastric cancer. We then evaluated the clinicopathological significance of hyperfibrinogenemia and its relationship with several biomarkers, including white blood cell (WBC), C-reactive protein (CRP), platelet count, prothrombin time (PT) and activated partial thromboplastin time (APTT). Postoperative plasma levels were compared with preoperative levels. The multivariate prognostic value of hyperfibrinogenemia was calculated using the Cox proportional hazards model.

Results

Tumor progression was significantly associated with hyperfibrinogenemia, as were the CRP level and platelet counts. Plasma fibrinogen levels decreased significantly after radical surgery. Adjusting for TNM factors, multivariate analysis indicated that hyperfibrinogenemia was an independent prognostic factor for poor survival (hazard ratio = 2.607, 95 % confidence interval = 1.180–5.761, P = 0.018).

Conclusion

Preoperative hyperfibrinogenemia was associated with tumor progression, inflammatory mediators, and poor overall survival in patients with gastric cancer.

Keywords

Gastric cancer Plasma fibrinogen Hyperfibrinogenemia 

Supplementary material

595_2016_1339_MOESM1_ESM.docx (111 kb)
Supplementary material 1 (DOCX 111 kb)

Funding information

Funder NameGrant NumberFunding Note
JSPS KAKENHI
  • 15K10117

Copyright information

© Springer Japan 2016

Authors and Affiliations

  • Takashi Suzuki
    • 1
  • Hideaki Shimada
    • 1
  • Tatsuki Nanami
    • 1
  • Yoko Oshima
    • 1
  • Satoshi Yajima
    • 1
  • Masaaki Ito
    • 1
  • Naohiro Washizawa
    • 1
  • Hironori Kaneko
    • 1
  1. 1.Department of Surgery, School of MedicineToho UniversityTokyoJapan

Personalised recommendations